Omicron-specific COVID-19 Vaccine

About Sinopharm

Sinopharm's mission is to safeguard national health security through its comprehensive pharmaceutical ecosystem. Its achievements include developing and deploying critical COVID-19 vaccines and maintaining China's primary drug supply chain. The company's strategy leverages its state-backed, vertically integrated structure to dominate domestic distribution while expanding its proprietary biopharmaceutical portfolio in vaccines, plasma products, and traditional Chinese medicine.

Therapeutic Areas